Entheogens & Emerging Therapies
There is a growing body of research into the therapeutic use of psilocybin, MDMA, and other entheogens, and it is inspiring policymakers, medical experts, and the public to reexamine drug policy at every level of government. Vicente Sederberg is committed to working with communities to develop sensible policy solutions that advance the public interest.
Vicente Sederberg has specialized in cannabis policy for over a decade, and we understand the complexities of transitioning a controlled substance from a prohibition model to a more nuanced system, in which it is decriminalized or regulated for research and other legal purposes. Our attorneys have extensive experience shaping decriminalization and regulatory policies in the U.S. and internationally, helping businesses, governments, advocates, and others understand and tactically navigate the interplay between local, state, and federal laws.
Laws, legal authorities, and avenues for reform vary from city to city and state to state. We help our clients craft and execute impactful strategies and policy reform movements tailored to the unique legal and political considerations that apply in each jurisdiction.
- Assisting clients and advocacy organizations with the creation, drafting, and strategic implementation of local and state controlled substance policy reform measures
- Assessing the risks for practitioners and other health care professionals in providing emerging therapies
- Helping professional organizations shape ethical guidelines for practitioners in emerging therapies to set the standards for best practices
- Providing corporate services for emerging therapies businesses, including forming benefit corporations
- Protecting the religious freedoms and first amendment rights of organizations traditionally involved in entheogen practices
- Assisted Decriminalize Denver with drafting and strategy for the successful 2019 Denver Psilocybin Initiative. The historic ballot measure designated possession of psilocybin mushrooms by persons 21 and older the city’s lowest law-enforcement priority, and it prohibited the city from spending resources to impose criminal penalties for such activities.
- Advised multiple clients engaging in legal entheogen-based therapy and related services, including drafting liability waivers and advising on corporate structure and procedure.
- Advised a technology company on legal issues related to entheogen therapies.
- Advised an entrepreneur regarding the legality of psilocybin production and research.
- Advised multiple clients regarding biosynthetic cannabinoid production, including legal analyses with regard to the Controlled Substance Act, the Federal Analogue Act, and similar laws at the state level.
- Advised a member of the Native American Church regarding unfair treatment by local law enforcement in connection with legal activities with entheogens.
In the Media
- Law360, "Psychedelic Meds Are Opening a New Frontier for Legal Work," May 8, 2020
- Marijuana Moment, "Oakland Activists Meet To Chart Path For Legal Sales Of Psychedelics," March 4, 2020
- Law Week Colorado, "First Comes Vote, Now Comes Implementation," June 12, 2019
- The Guardian, "'A grand experiment': how 'shrooms made Denver America's most drug-friendly city," May 19, 2019
- Reason, "Will Decriminalizing Psilocybin Hasten the End of the War on Drugs?," May 9, 2019
- KMGH ABC 7 Denver , "What's Next Now that the Magic Mushrooms Initiative Passed in Denver?," May 9, 2019
- Westword, "How Psilocybin Advocates Grew Denver's Trippiest Ballot Initiative," April 16, 2019
- Denver Post, "Legal vs. Decriminalized: Unpacking Denver’s Psilocybin Initiative," March 18, 2019
- Denver Post, "It’s official: Psychedelic mushrooms are on a trip to Denver’s 2019 election ballot," February 1, 2019
- The Rooster, "Mushroom legalization in Colorado gains both political and legal support," September 14, 2018